PDE3B and Hepatic steatosis: On the other hand, in a study with mice overexpressing PDE3B, there was an early and striking appearance of hyperglycemia, islet dysfunction, glucose intolerance, insulin resistance, and hepatic steatosis when challenged with HFD [29].